Determination of pantoprazole in tablet dosage forms by two different spectrophotometric methods

Fabad Journal of Pharmaceutical Sciences

Volumn 28, Issue 2, 2004, Pages 85-92

  Süslü, Incilay ^a   Altinöz, Sacide ^a   Yildiz, Emine ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

First Derivative UV Spectrophotometry; Pantoprazole; Tablet Dosage Form; UV Spectrophotometry

Indexed keywords

EXCIPIENT; PANTOPRAZOLE; PANTPAS; PROTON PUMP INHIBITOR;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG DOSAGE FORM; SPECTRAL SENSITIVITY; SPECTROPHOTOMETRY; TABLET; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 2942708067     PISSN: 13004182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Poole P. Pantoprazole, Am. Health Syst. Pharm., 58 (11), 999-1008, 2001.
2. Bruni AT, Leite VB, Ferreira MM. Conformational analysis: a new approach by means of chemometrics, J. Comput. Chem., 23 (2), 222-236, 2002.
3. Tanaka M, Yamazaki H, Ryakowa Y, Hakusui H, Nakamichi N, Sekino H. Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers, Int. J. Clin. Pharmacol. Ther., 34 (10), 415-419, 1996.
4. Tanaka M, Yamazaki H, Hakusui H, Nakamichi N, Sekino H. Differential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole, Chirality, 9 (1), 17-21, 1997.
5. Playford RJ, Podas T, Modlin I. Pantoprazole, Prout and the proton pump, Hosp. Med., 60 (7), 500-504, 1999.
6. 2 receptor antagonists and proton pump inhibitors: principles and rules of use, Rev. Prat., 51 (7), 789-795, 2001.
7. Huber R, Hartmann M, Bliesath H, Luhmann R, Steinijans VW, Zech K. Pharmacokinetics of pantoprazole in man, Clin. Pharmacol. Ther., 34 (5), 185-194, 1996.
8. Cass QB, Degani ALG, Cassiano NM, Pedrazolli JJ. Enantiomeric determination of pantoprazole in human plasma by multidimensional high-performance liquid chromatography, J. Chromatogr. B, 766, 153-160, 2001.
9. Mansour AM, Sorour OM. High-performance liquid chromatographic determination of pantoprazole in tablet dosage form, Chromatographia, 53, 478-479, 2001.
10. Tanaka M, Yamazaki H, Hakusui H. Direct HPLC separation of enantiomers of pantoprazole and other benzimidazole sulfoxides using cellulose based chiral stationary phases in reversed-phase mode, Chirality, 7 (8), 612-615, 1995.
11. Jiao X, Duan J, Si K, Huang X, Liu D, Yan B. Determination of pantoprazole in plasma by HPLC, Zhongguo Yaoxue Zazhi (Beijing), 34 (7), 483-485, 1999.
12. Tanaka M, Yamazaki H. Direct determination of pantoprazole enantiomers in human serum by reversed-phase high-performance liquid chromatography using a cellulose-based chiral stationary phase and column-switching system as a sample cleanup procedure, Anal. Chem., 68 (9), 1513-1516, 1996.
13. Ekpe A, Jacobsen T. Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography, Drug Dev. Ind. Pharm., 25 (9), 1057-1065, 1999.
14. Tivesten A, Folestad S, Schonbacher V, Svensson K. Nonaqueous capillary electrophoresis for the analysis of labile pharmaceutical compounds, Chromatographia, 49 (1), 7-11, 1999.
15. Daniela E, Rolf PH, Reinhard K. Chiral resolution of pantoprazole sodium and related sulfoxides by complex formation with bovine serum albumin in capillary electrophoresis, J. Chromatogr. A, 759, 185-192, 1997.
16. Azza AMM. Spectrophotometric methods for the determination of lansoprazole and pantoprazole sodium sesquihydrate, J. Pharm. Biomed. Anal., 22, 45-58, 2000.
17. Abdel-Aziz MW, Omayma A, Azza AG, Hoda M, Marwa SM. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations, J. Pharm. Biomed. Anal., 30, 1133-1142, 2002.
18. Karljikovic-Rajic K, Novovic D, Marinkovic V, Agbaba D. First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities, J. Pharm. Biomed. Anal., 32, 1019-1027, 2003.
19. International Conference on Harmonization (ICH) Topic Q2A, Validation of Analytical Procedures; Methodology, CPMP / ICH /281, 1995.
20. The United States Pharmacopeia (USP) 24th United States Pharmacopeial Convention Incoporate: Rockville, M. D. 2149, 2000.